Elevated sLOX-1 levels in the circulation were significantly associated with the incidence of coronary artery disease and ischemic stroke and were therefore proposed as useful diagnostic and prognostic biomarkers for evaluating the state and risk of atherosclerosis and atherosclerosis-related diseases (for reviews see refs. 8,14–16). The gene discussed is OLR1; the disease is atherosclerosis.